{"effective_time":"20111222","id":"b52ba2cd-9d40-4278-9509-790475640c05","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL - 50 mg Vial Carton NDC 10885-001-01 DaunoXome ® (daunorubicin citrate liposome injection) 50 mg/vial (2 mg/mL) FOR INTRAVENOUS INFUSION ONLY Note: Liposomal Formulation - See Package Insert Prior To Use. Single Use Vial, Sterile, Preservative - Free Refrigerate, 2°-8°C (36°-46°F). Do not freeze. Protect from light. See package insert for information on dosage and administration. GALEN Manufactured for: Galen US Inc. 25 Fretz Road, Souderton PA 18964 PRINCIPAL DISPLAY PANEL - 50 mg Vial Carton"],"set_id":"6fb6d2fc-5d8d-4eea-bf91-f5afd1789d63","spl_product_data_elements":["DaunoXome daunorubicin citrate daunorubicin citrate daunorubicin distearoylphosphatidylcholine, DL- cholesterol sucrose glycine calcium chloride"],"version":"1"}